George L. Sing

Co-Founder at Lancet Capital Partners LLC

George L. Sing

George L. Sing

Co-Founder at Lancet Capital Partners LLC

Overview
Career Highlights

Lancet Capital Partners LLC
Noveome Biotherapeutics, Inc.
Merrill Lynch Ventures LLC

RelSci Relationships

743

Number of Boards

4

Birthday

1950

Age

69

Contact Data
Trying to get in touch with George L. Sing? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals George L. Sing likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Noveome Biotherapeutics, Inc.

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founding Scientist at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Medical Officer & Vice President-Medical Affairs at Noveome Biotherapeutics, Inc.

Relationship likelihood: Strong

Founder at Lux Biosciences, Inc.

Relationship likelihood: Strong

Vice Chairman of the Supervisory Board & Secretary at Koninklijke Philips NV

Relationship likelihood: Strong

Director, Sales & Marketing at RF Monolithics, Inc.

Relationship likelihood: Strong

Former Founder & Director at Peloton Therapeutics, Inc.

Relationship likelihood: Strong

Professor & Chairman-Molecular Genetics Department at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

Professor Emeritus, Department of Neurobiology at Stanford University - School of Medicine

Relationship likelihood: Strong

Paths to George L. Sing
Potential Connections via
Relationship Science
You
George L. Sing
Co-Founder at Lancet Capital Partners LLC
Education
Bachelor of Engineering

Stevens Institute of Technology The Innovation University®, is a premier, private research university situated in Hoboken, N.J. overlooking the Manhattan skyline. Founded in 1870, technological innovation has been the hallmark and legacy of Stevens’ education and research programs for more than 140 years. Within the university’s three schools and one college, more than 6,100 undergraduate and graduate students collaborate with more than 350 faculty members in an interdisciplinary, student-centric, entrepreneurial environment to advance the frontiers of science and leverage technology to confront global challenges. Stevens is home to three national research centers of excellence, as well as joint research programs focused on critical industries such as healthcare, energy, finance, defense and STEM education. The university is the fastest-rising college in the U.S. News & World Report ranking of the best national universities, and it is consistently ranked among the nation’s elite for return on investment for students, career services programs, and mid-career salaries of alumni. Stevens is in the midst of a 10-year strategic plan, The Future. Ours to Create., designed to further extend the Stevens legacy to create a forward-looking and far-reaching institution with global impact

Master of Business Administration

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Co-Founder
Current

Lancet Capital focuses on early-stage, emerging biomedical technologies and opportunities including bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics and diagnostic systems.

Co-Founder
2004 - 2015

Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA.

Founder
Prior

Merrill Lynch Ventures (MLV) specializes in early venture, LBOs, financial restructuring and reorganization investments. The firm focuses on investments in the technology, telecommunications and healthcare sectors.Investments typically range from $10 million to $15 million

Political Donations
$1,250
2010

Representative from Pennsylvania's 18th Congressional District

$2,300
2007

Representative from Pennsylvania's 18th Congressional District

$1,000
2006

Representative from Pennsylvania's 18th Congressional District

Transactions
Details Hidden

Noveome Biotherapeutics, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by George L. Sing. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of George L. Sing's profile does not indicate a business or promotional relationship of any kind between RelSci and George L. Sing.